skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: SU-E-T-675: Remote Dosimetry with a Novel PRESAGE Formulation

Abstract

Purpose: 3D-gel dosimetry provides high-resolution treatment validation; however, scanners aren’t widely available. In remote dosimetry, dosimeters are shipped out from a central base institution to a remote site for irradiation, then shipped back for scanning and analysis, affording a convenient service for treatment validation to institutions lacking the necessary equipment and resources. Previous works demonstrated the high-resolution performance and temporal stability of PRESAGE. Here the newest formulation is investigated for remote dosimetry use. Methods: A new formulation of PRESAGE was created with the aim of improved color stability post irradiation. Dose sensitivity was determined by irradiating cuvettes on a Varian Linac (6MV) from 0–15Gy and measuring change in optical density at 633nm. Sensitivity readings were tracked over time in a temperature control study to determine long-term stability. A large volume study was performed to evaluate the accuracy for remote dosimetry. A 1kg dosimeter was pre-scanned, irradiated on-site with an 8Gy 4field box treatment, post-scanned and shipped to Princess Margaret Hospital for remote reading on an identical scanner. Results: Dose sensitivities ranged from 0.0194–0.0295 ΔOD/(Gy*cm)—similar to previous formulations. Post-irradiated cuvettes stored at 10°C retained 100% initial sensitivity over 5 days and 98.6% over 10 weeks while cuvettes stored at room temperaturemore » fell to 95.8% after 5 days and 37.4% after 10 weeks. The immediate and 5-day scans of the 4field box dosimeter data was reconstructed, registered to the corresponding eclipse dose-distribution, and compared with analytical tools in CERR. Immediate and 5-day scans looked visually similar. Line profiles revealed close agreement aside from a slight elevation in dose at the edge in the 5-day readout. Conclusion: The remote dosimetry formulation exhibits excellent temporal stability in small volumes. While immediate and 5-day readout scans of large volume dosimeters show promising agreement, further development is required to reduce an apparent time dependent edge elevation.« less

Authors:
; ;  [1];  [2];  [3]
  1. Duke University Medical Physics Graduate Program, Durham, NC (United States)
  2. Rider University, Lawrenceville, NJ (United States)
  3. Dept. of Radiation Oncology, Duke University Medical Center, Durham, NC (United States)
Publication Date:
OSTI Identifier:
22538182
Resource Type:
Journal Article
Resource Relation:
Journal Name: Medical Physics; Journal Volume: 42; Journal Issue: 6; Other Information: (c) 2015 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; DOSEMETERS; DOSIMETRY; GY RANGE; IRRADIATION; LINEAR ACCELERATORS; RADIATION DOSE DISTRIBUTIONS; READOUT SYSTEMS; SENSITIVITY; STABILITY; TEMPERATURE CONTROL; TEMPERATURE RANGE 0273-0400 K; TIME DEPENDENCE

Citation Formats

Mein, S, Juang, T, Malcolm, J, Adamovics, J, and Oldham, M. SU-E-T-675: Remote Dosimetry with a Novel PRESAGE Formulation. United States: N. p., 2015. Web. doi:10.1118/1.4925038.
Mein, S, Juang, T, Malcolm, J, Adamovics, J, & Oldham, M. SU-E-T-675: Remote Dosimetry with a Novel PRESAGE Formulation. United States. doi:10.1118/1.4925038.
Mein, S, Juang, T, Malcolm, J, Adamovics, J, and Oldham, M. Mon . "SU-E-T-675: Remote Dosimetry with a Novel PRESAGE Formulation". United States. doi:10.1118/1.4925038.
@article{osti_22538182,
title = {SU-E-T-675: Remote Dosimetry with a Novel PRESAGE Formulation},
author = {Mein, S and Juang, T and Malcolm, J and Adamovics, J and Oldham, M},
abstractNote = {Purpose: 3D-gel dosimetry provides high-resolution treatment validation; however, scanners aren’t widely available. In remote dosimetry, dosimeters are shipped out from a central base institution to a remote site for irradiation, then shipped back for scanning and analysis, affording a convenient service for treatment validation to institutions lacking the necessary equipment and resources. Previous works demonstrated the high-resolution performance and temporal stability of PRESAGE. Here the newest formulation is investigated for remote dosimetry use. Methods: A new formulation of PRESAGE was created with the aim of improved color stability post irradiation. Dose sensitivity was determined by irradiating cuvettes on a Varian Linac (6MV) from 0–15Gy and measuring change in optical density at 633nm. Sensitivity readings were tracked over time in a temperature control study to determine long-term stability. A large volume study was performed to evaluate the accuracy for remote dosimetry. A 1kg dosimeter was pre-scanned, irradiated on-site with an 8Gy 4field box treatment, post-scanned and shipped to Princess Margaret Hospital for remote reading on an identical scanner. Results: Dose sensitivities ranged from 0.0194–0.0295 ΔOD/(Gy*cm)—similar to previous formulations. Post-irradiated cuvettes stored at 10°C retained 100% initial sensitivity over 5 days and 98.6% over 10 weeks while cuvettes stored at room temperature fell to 95.8% after 5 days and 37.4% after 10 weeks. The immediate and 5-day scans of the 4field box dosimeter data was reconstructed, registered to the corresponding eclipse dose-distribution, and compared with analytical tools in CERR. Immediate and 5-day scans looked visually similar. Line profiles revealed close agreement aside from a slight elevation in dose at the edge in the 5-day readout. Conclusion: The remote dosimetry formulation exhibits excellent temporal stability in small volumes. While immediate and 5-day readout scans of large volume dosimeters show promising agreement, further development is required to reduce an apparent time dependent edge elevation.},
doi = {10.1118/1.4925038},
journal = {Medical Physics},
number = 6,
volume = 42,
place = {United States},
year = {Mon Jun 15 00:00:00 EDT 2015},
month = {Mon Jun 15 00:00:00 EDT 2015}
}
  • Purpose: To introduce and characterize novel water-equivalent PRESAGE dosimeters for megavoltage and kilovoltage X-ray beam dosimetry. Methods: Three novel metal-optimized PRESAGE dosimeters referred to as MO-PRESAGE 1, 2 and 3 were formulated. The radiological properties were key factors that were considered when formulating the new dosimeters. All formulations were prepared in spectrophotometric cuvettes, irradiated with a 6 MV X-ray beam, and the change in optical density was measured using a spectrophotometer. Their sensitivity, post-response stability, and water equivalency were investigated. Results: The results showed that all three formulations exhibited radiological properties closer to water than any of the commercially availablemore » PRESAGE formulations. For example, the novel MO-PRESAGE 1, 2 and 3 have mass densities only 3.9-4.4% higher than that of water, whereas the mass density for the commercial formulation is 5.3% higher. The novel formulations have almost identical Zeff values to that of water (7.42), while the Zeff for the commercial formulation was 3.7% higher than that of water. In addition, the MO-PRESAGE 3 formulation showed mass and energy attenuation coefficients that deviated from those of water by less than 50% relative to the commercial formulation. Furthermore, the reduced Zeff of the three different MOPRESAGE formulations resulted in a maximum variation in the probability of photoelectric absorption of 1.3 times than of water, compared to 1.8 times that of water for the commercial formulation. MO-PRESAGE 3 was also more sensitive to radiation than the other two new formulations introduced in this work due to the presence of alkylbromide radical initiators in the MO-PRESAGE 3 formulation. Conclusion: All three novel MOPRESAGE dosimeter formulations displayed excellent radiological properties, superior to any of the commercially available PRESAGE formulations and thus can be used for the dosimetry of clinical megavoltage and kilovoltage X-ray beams.« less
  • Purpose: The radiochromic polyurethane PRESAGE by Heuris Pharma has had limited applications with protons because of a dose response dependence on LET resulting in signal quenching in the Bragg peak. This is due to the radical initiator, a halocarbon, radically recombining in high-LET irradiations. This study investigated the use of alternative halocarbons at various chemical concentrations to determine their significance in signal quenching. Methods: PRESAGE was manufactured in-house and cast in small volume cuvettes (1×1×4cm^3). Several compositions were evaluated to determine the influence of the radical initiator component. Mixtures contained one of two halocarbons, chloroform or bromoform, at concentrations ofmore » 5%/10%/15%(w/w). A large volume, cylindrical PRESAGE dosimeter made following the mixture described by Heuris Pharma, 4cm(D)×8.5cm(H), was irradiated with 200-MeV protons to study regions of low- and high-LET along a 10cm spread out Bragg peak isodose profile. Depths corresponding to regions of low quenching (<3%) and high quenching (>20%) were determined. These depths were used for cuvette placement in a solid water phantom. Samples of each formulation were placed at each depth and irradiated to doses between 0 and 10Gy. Results: The cuvettes indicated different levels of quenching for different radical initiator types, concentrations, and total doses. Chloroform formulations showed reduced quenching from 29%(5%-w/w) to 21%(15%-w/w) while bromoform reduced quenching from 27%(5%-w/w) to 17%(15%-w/w). The reduction in quenching was found to be non-linear with concentration of radical initiator. A quenching dose-dependency was also found that changed with formulation. In all cases, quenching was relatively consistent from 0–5Gy but increased at 10Gy. The quenching decreased as concentrations of radical initiator increased. Conclusion: The radical initiator component in PRESAGE is correlated with the signal quenching observed in proton irradiations and formulation adjustments show promise as a method of reducing this quenching. Future work will further investigate concentration limits and optimize the formulation. Grant number 5RO1CA100835.« less
  • Purpose: To validate the use of a PRESAGE dosimeter as a method to quantitatively measure dose distributions of injectable brachytherapy based on elastin-like polypeptide (ELP) nanoparticles. PRESAGE is a solid, transparent polyurethane-based dosimeter whose dose is proportional to a change in optical density, making it useful for visualizing the dose from a radionuclide-tagged-ELP injection. Methods: A PRESAGE dosimeter was designed to simulate an ELP injection. To calibrate, cuvette samples from the batch of PRESAGE were exposed to varying levels of radiation from 0–35.9Gy applied via a linear accelerator, then placed into a spectrophotometer to obtain the optical density change asmore » a function of dose. A pre-optical-CT scan was acquired of the phantom to obtain a baseline tomographic optical density. A 1cc saline solution of I-125 tagged-ELP with and activity concentration of 1mCi/cc was injected into the phantom and left for five days. After five days, the ELP was removed and the cavity cleaned of all remaining radioactive material. Post tomographic optical images were acquired to obtain a differential optical density dataset. Results: Initial results after the 5-day exposure revealed an opaque white film that resembled the volume of the ELP solution injected into the phantom. We think this is possibly due to the saline solution diffusing into the PRESAGE and causing a change in the index of refraction at this shallow depth. Therefore, initially the optical scanner yielded inconclusive results. After several more days, the saline seemed to have evaporated out of the injection site and the ELP dose distribution was visible via color change in the dosimeter. Conclusion: We have created the first experimental design to measure the dose distribution of I-125-tagged-ELP. The PRESAGE formulation proves to be a feasible option for such measurements. Future experimental measurements need to be obtained to further characterize ELP dosimetry.« less
  • Purpose: Measurement of positron emission following proton beam irradiation of a target has been studied as a method of in-vivo dosimetry. Relative dosimetry studies between a phantom and treatment plan are susceptible to range uncertainties from material heterogeneities and setup error. By using the radiochromic polyurethane dosimeter PRESAGE, we can correlate the proton dose distribution to the PET activity measurement within a single detector. The PRESAGE formulation used was developed for high-LET proton radiotherapy, has similar density and RLSP to tissue, and consists of a greater carbon component, which gives it a higher positron signal than many other 3D detectors.more » Methods: Three cylindrical PRESAGE dosimeters were irradiated semi-uniformly to 500 cGy with 180- MeV protons. The beam was directed along the dosimeter axis and delivered a 2-cm SOBP at the center of the dosimeter. The dosimeters were rushed to a nearby PET/CT where imaging began within 15 minutes, less than a single half-life of 11C. A 3-hr measurement captured the full activation decay. Afterwards, the dose profiles were measured by optical-CT. A direct comparison between the measured dose and the positron emission was performed using CERR software. Results: The correlations between dose distributions and PET activity were consistent with previous studies in that the proximal region of the SOBP displayed the highest activity. The spatial distributions between the dose and activity were similar. Along the central axis of the beam, we found a shift in the distal 80% of 1 cm. The lateral profile showed good agreement between dose and activity. PET imaging times between 30-min and 3-hrs showed <5% discrepancy. Conclusion: PRESAGE dosimeters offer a strong and unique potential to accurately correlate dosimetric and PET activation information. Implementation in an anthropomorphic phantom could be used to study representative treatment plans. NIH grant 5R01CA100835.« less
  • Purpose: To quantify the sensitivity and stability of the Presage dosimeter in sheet form for different concentrations of chemicals and for a diverse range of clinical photon energies. Methods: Presage polymer dosimeters are formulated to investigate and optimize their sensitivity and stability. The dosimeter is composed of clear polyurethane base, leucomalachite green reporting dye, and bromoform radical initiator in 1mm thick sheets. The chemicals are well mixed together, cast in an aluminum mold, and left to cure at 60 psi for a minimum of 2 days. Dosimeter response will be characterized at multiple energies including Co-60, 6 MV, 15 MV,more » 50 kVp, and 250 kVp. The dosimeters are read by an Epson 10000 XL scanner at 800 dpi, 2{sup 16} bit depth. Red component images are analyzed with ImageJ. Results: Analysis of optical density verse dose for Co-60 energies indicates that the bromoform containing Presage was able to quantify dose from 0 to 300 Gy, with saturation beyond 300 Gy. Initial results show two regions of linear response, 0–100 Gy and 150–300 Gy. The 150–300 Gy region has a sensitivity of 0.0024 net OD/Gy. Further results on other energies are still in progress. Conclusions: This work shows the potential for use of thin sheets of Presage dosimeter as a dosimeter capable of being analyzed with a flatbed scanner.« less